These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 6638011)
1. A rapid in vitro drug-sensitivity assay in acute nonlymphocytic leukemia. Theodorakis ME; Goldberg J Am J Hematol; 1983 Nov; 15(3):261-71. PubMed ID: 6638011 [TBL] [Abstract][Full Text] [Related]
2. Comparison of in vitro and in vivo effects of vincristine and vindesine on leukemic cells from patients with chronic granulocytic leukemia in blast crisis. Theodorakis ME; Goldberg J Leuk Res; 1984; 8(6):1065-71. PubMed ID: 6595480 [TBL] [Abstract][Full Text] [Related]
3. Predictive value of in vitro colony and cluster formation in acute nonlymphocytic leukemia. Goldberg J; Tice D; Nelson DA; Gottlieb AJ Am J Med Sci; 1979; 277(1):81-4. PubMed ID: 426001 [TBL] [Abstract][Full Text] [Related]
4. Treatment of acute nonlymphocytic leukemia in elderly patients: a prospective study of intensive chemotherapy. Peterson BA; Bloomfield CD Cancer; 1977 Aug; 40(2):647-52. PubMed ID: 890652 [TBL] [Abstract][Full Text] [Related]
5. Prediction of chemotherapy response in human leukemia using an in vitro chemotherapy sensitivity test on the leukemic colony-forming cells. Park CH; Amare M; Savin MA; Goodwin JW; Newcomb MM; Hoogstraten B Blood; 1980 Apr; 55(4):595-601. PubMed ID: 7357086 [TBL] [Abstract][Full Text] [Related]
6. [An in vitro chemotherapy sensitivity test on leukemic colony-forming cells (L-CFU) and its clinical evaluation]. Moriyama Y; Urushiyama M; Hirosawa H; Koyama S; Takai K; Fujiwara M; Kishi K; Takahashi M; Sakai C; Sanada M; Shibata A Gan To Kagaku Ryoho; 1982 Oct; 9(10):1749-54. PubMed ID: 7184371 [TBL] [Abstract][Full Text] [Related]
7. Therapy in childhood acute nonlymphocytic leukemia (ANLL). Evolution of current concepts of chemotherapy. Steuber CP Am J Pediatr Hematol Oncol; 1981; 3(4):379-88. PubMed ID: 6174052 [TBL] [Abstract][Full Text] [Related]
8. Aclarubicin in the treatment of acute nonlymphocytic leukemia refractory to treatment with daunorubicin and cytarabine: a phase II trial. Pedersen-Bjergaard J; Brincker H; Ellegaard J; Drivsholm A; Freund L; Jensen KB; Jensen MK; Nissen NI Cancer Treat Rep; 1984 Oct; 68(10):1233-8. PubMed ID: 6597002 [TBL] [Abstract][Full Text] [Related]
9. Chemotherapy for adult acute nonlymphocytic leukemia with daunorubicin and cytosine arabinoside. Cassileth PA; Katz ME Cancer Treat Rep; 1977 Nov; 61(8):1441-5. PubMed ID: 922749 [TBL] [Abstract][Full Text] [Related]
10. In vitro correlates of low dose ara-C efficacy: clinical, cytogenetic, and bone marrow culture analysis. Weisdorf DJ; Perri RT; Arthur DC; Machnicki JL; Oken MM; Miller WJ Am J Hematol; 1987 May; 25(1):43-53. PubMed ID: 3578263 [TBL] [Abstract][Full Text] [Related]
11. The clonogenic assay as a reproducible in vitro system to study predictive parameters of treatment outcome in acute nonlymphoblastic leukemia. Browman G; Goldberg J; Gottlieb AJ; Preisler HD; Azarnia N; Priore RL; Brennan JK; Vogler WR; Winton EF; Miller KB Am J Hematol; 1983 Nov; 15(3):227-35. PubMed ID: 6638009 [TBL] [Abstract][Full Text] [Related]
12. Chemotherapy sensitivity assessment of leukemic colony-forming cells with in vitro simultaneous exposure to multiple drugs: clinical correlations in acute nonlymphocytic leukemia. Park CH; Amare M; Morrison FS; Maloney TR; Goodwin JW Cancer Treat Rep; 1982 Jun; 66(6):1257-61. PubMed ID: 7083232 [TBL] [Abstract][Full Text] [Related]
13. High-dose cytosine arabinoside and daunorubicin as consolidation therapy for acute nonlymphocytic leukemia in first remission: an update. Wolff SN; Herzig RH; Phillips GL; Lazarus HM; Greer JP; Stein RS; Ray WA; Herzig GP Semin Oncol; 1987 Jun; 14(2 Suppl 1):12-7. PubMed ID: 3589687 [TBL] [Abstract][Full Text] [Related]
14. Intensive postremission chemotherapy in adults with acute myeloid leukemia. Cancer and Leukemia Group B. Mayer RJ; Davis RB; Schiffer CA; Berg DT; Powell BL; Schulman P; Omura GA; Moore JO; McIntyre OR; Frei E N Engl J Med; 1994 Oct; 331(14):896-903. PubMed ID: 8078551 [TBL] [Abstract][Full Text] [Related]
15. Growth and differentiation patterns of human acute non lymphoid leukemia in diffusion chambers before and after treatment. Izzi T; Fontebuoni A; Lucarelli G Blut; 1981 Jul; 43(1):25-31. PubMed ID: 7260400 [TBL] [Abstract][Full Text] [Related]
16. Cytosine arabinoside (NSC-63878) and daunorubicin (NSC-83142) therapy in acute nonlymphocytic leukemia. Yates JW; Wallace HJ; Ellison RR; Holland JF Cancer Chemother Rep; 1973; 57(4):485-8. PubMed ID: 4586956 [No Abstract] [Full Text] [Related]
17. Pediatric Oncology Group Study of in vitro clonal growth patterns of leukemic cells in childhood acute nonlymphocytic leukemia as a predictor of induction response. Findley HW; Steuber CP; Krischer JP; Ragab AH Cancer Res; 1987 Aug; 47(15):4225-8. PubMed ID: 3607762 [TBL] [Abstract][Full Text] [Related]
18. Adult acute nonlymphocytic leukemias. Dabich L Med Clin North Am; 1980 Jul; 64(4):683-704. PubMed ID: 6995730 [TBL] [Abstract][Full Text] [Related]
19. Treatment of patients with acute nonlymphocytic leukemia in relapse: a Leukemia Intergroup study. Goldberg J; Grunwald H; Vogler WR; Winton E; Browman G; Walker I; Benger A; Miller KB; Rai K; Gottlieb AJ Am J Hematol; 1985 Jun; 19(2):167-76. PubMed ID: 3890525 [TBL] [Abstract][Full Text] [Related]
20. Clinical correlations of leukemic clonogenic cell chemosensitivity assessed by in vitro continuous exposure to drugs. Park CH; Wiernik PH; Morrison FS; Amare M; Van Sloten KV; Maloney TR Cancer Res; 1983 May; 43(5):2346-9. PubMed ID: 6572563 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]